Mutual of America Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-53,350
Closed -$2.1M 1498
2023
Q2
$2.1M Buy
+53,350
New +$1.88M 0.02% 896
2016
Q4
Sell
-800
Closed -$37K 1224
2016
Q3
$37K Hold
800
﹤0.01% 1205
2016
Q2
$41K Buy
800
+200
+33% +$9.94K ﹤0.01% 1198
2016
Q1
$25K Buy
600
+200
+50% +$10.2K ﹤0.01% 1210
2015
Q4
$31K Sell
400
-550
-58% -$31.8K ﹤0.01% 1211
2015
Q3
$38K Buy
950
+200
+27% +$10.6K ﹤0.01% 1204
2015
Q2
$39K Hold
750
﹤0.01% 1210
2015
Q1
$35K Hold
750
﹤0.01% 1214
2014
Q4
$34K Sell
750
-350
-32% -$14.7K ﹤0.01% 1206
2014
Q3
$43K Buy
+1,100
New +$43.2K ﹤0.01% 1192

Mutual of America Capital Management's ISEE Position: Q3 2023 in Review

Mutual of America Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 53,350 shares — an estimated $2.1M sold.

Mutual of America Capital Management first reported a position in ISEE in Q3 2014 and held it in 10 quarters. The position peaked at $2.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Mutual of America Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Mutual of America Capital Management sold 53,350 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.1M.
  • Mutual of America Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 10 quarters.
  • Mutual of America Capital Management's IVERIC bio, Inc. Common Stock position peaked at $2.1M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Mutual of America Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.